No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Memic Announces Multiple Upcoming Presentations of Hominis Surgical System at Society of Robotic and Digital Surgery 2022 Annual Meeting

Editor: What To Know

  • (Memic), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that multiple abstracts detailing clinical data related to the Hominis Surgical System for robotic-assisted transvaginal hysterectomy were accepted for presentation at the Society of Robotic and Digital Surgery (SRS) 2022 Annual Meeting, taking place June 30-July 3 at the Disney Yacht &.
  • In addition, the company plans to host a special on-site event called “Project M” for employees and surgeons on Friday, July 1 at 6.
  • The company will also host hands-on demonstrations in its on-site booth (#5) where surgeons can experience using the Hominis System firsthand and practice performing surgeries with a virtual reality simulator program to support surgeon skills training and education.

Memic Innovative Surgery Ltd. (Memic), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that multiple abstracts detailing clinical data related to the Hominis Surgical System for robotic-assisted transvaginal hysterectomy were accepted for presentation at the Society of Robotic and Digital Surgery (SRS) 2022 Annual Meeting, taking place June 30-July 3 at the Disney Yacht & Beach Club Resort in Florida.

Details of the Memic presentations at SRS are as follows:

Fireside Chat

Title: Fireside Chat: Pioneering New Platforms in Surgical Robotics: Memic, Senhance, Insightec

Presenter: Dvir Cohen, CEO, Memic

Date and Time: Thursday, June 30, 2022 from 12:45-1:15 p.m. ET

Location: Asbury A-C

Oral Presentations

Title: The Future of Soft Tissue Robotics is Now

Presenter: Michael A. Conditt, PhD, senior vice president, strategic marketing & clinical development, Memic

Date and Time: Friday, July 1, 2022 from 8:15-8:30 a.m. ET

Location: Asbury A-C

Title: Hominis Robotic Platform: Vaginal Robotics

Presenters: Ricardo E. Estape, MD, gynecologic surgeon and director, HCA Florida Institute for Gynecologic Oncology, Kendall Hospital and Erica Stockwell, DO, MBA, FACOG, gynecologic surgeon, AdventHealth Celebration

Date and Time: Saturday, July 2, 2022 from 1:30-1:40 p.m. ET

Location: Asbury D

Title: Design of a Robotic Surgery Console to Optimize User Ergonomics

Presenters: Thomas P. Heffernan, MD, gynecologic oncologist, Medical City Plano; Dr. Estape; Daniel Z. Michaeli, user experience lead, Memic; Matthew T. McKittrick, MBA, strategic marketing, Memic; and Dr. Conditt
Date and Time: Friday, July 1, 2022 from 4:20-5:00 p.m. ET

Location: Asbury D

Poster Number: G-9

Title: Quantifying a Comprehensive Training Protocol for a Novel Transvaginal Robotic System

Presenters: Dr. Stockwell, Dr. Conditt and Michael A. Hall, senior director, professional education, Memic

Date and Time: Friday, July 1, 2022 from 4:20-5:00 p.m. ET

Location: Asbury D

Poster Number: G-8

Poster Presentations

Title: Novel Single-port Robotic Platform for Bilateral Inguinal Hernia Repair

Authors: Eduardo Parra-Davila, MD, FACS, FASCRS; Dr. Conditt; Hamed Yaghini, MSc; Chris Lightcap, PhD; and Mr. McKittrick

Poster Number: GS15

Title: Novel Single-port Robotic Right Hemicolectomy Surgical Robotics Platform:  Access and Reach

Authors: Drs. Parra-Davila, Lightcap and Conditt, Mr. Yaghini and Mr. McKittrick

Poster Number: GS18 

Title: Eliminating the Fulcrum Point with a Transformative Single Port Robotic Surgery Platform

Authors: Drs. Conditt and Lightcap and Mr. Yaghini and Mr. McKittrick

Poster Number: GS19

Memic, who is sponsoring the meeting, will hold an industry product theatre titled “A Novel Approach to Robotics Assisted Vaginal Surgery” on Saturday, July 2 from 12:00-1:00 p.m. ET in Salon 1-3 during which Dr. Estape, the first surgeon in the U.S. to successfully complete a patient procedure using the Hominis System, will discuss his clinical experience with this technology and Dr. Stockwell, principal investigator of our real-world patient registry, will discuss several topics including the importance of building real-world clinical data and the history of robotic surgery such as the shift to performing hysterectomies using the transvaginal approach. The company will also host hands-on demonstrations in its on-site booth (#5) where surgeons can experience using the Hominis System firsthand and practice performing surgeries with a virtual reality simulator program to support surgeon skills training and education.

In addition, the company plans to host a special on-site event called “Project M” for employees and surgeons on Friday, July 1 at 6:00 p.m. ET in the Newport Ballroom immediately following the SRS Welcome Reception.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy